Therapeutics For Women's Health Technology Market is Estimated to Grow at CAGR of 5%, 2020-2029 | Latest Industry Coverage by Douglas Insights
Douglas Insights
Updated 9 min read
Douglas Insights
The market for therapeutics for women's health technology is expected to grow by a compound annual growth rate (CAGR) of 5%. This won't come as a surprise considering the fact that more and more women are becoming aware of the importance of maintaining their good health. The expected growth in this market is increased awareness about female-specific medical conditions, including endometriosis, breast cancer, menopause, postmenopausal osteoporosis, and PCOS.
Isle of Man, Nov. 01, 2022 (GLOBE NEWSWIRE) -- We've recently updated our comparison engine to feature research reports on women's health technology. The newest addition to the Douglas Insights comparison engine empowers researchers, experts, and businesses to identify growth drivers, obstacles, trends, and more.
Douglas Insights is a reliable tool providing quick access to the largest array of public and private reports about therapeutics for the women's health technology market. It allows analysts and researchers to quickly search through millions of reports about the women's health technology market, giving them unlimited access to valuable information. Users can compare different reports by publication date, table of contents, publisher ratings, pricing ranking, and more.
Analysts can extract quality information and resources with Douglas Insights for better decision-making and findings. The best way to get started is to select three reports on women's health therapeutics and then compare them. The powerful analytic engine generates quality insights without user interaction, making the process of finding information easy. With all this in place, it becomes crucial to extract information and compare it in order to get a better outcome.
The market for therapeutics for women's health technology is expected to grow by a compound annual growth rate (CAGR) of 5%. This won't come as a surprise considering the fact that more and more women are becoming aware of the importance of maintaining their good health. The expected growth in this market is increased awareness about female-specific medical conditions, including endometriosis, breast cancer, menopause, postmenopausal osteoporosis, and PCOS.
Therapeutics for women's health refers to medical treatments, devices, and services for diagnosing and improving women's health. Over the years, ongoing research has been performed to assess and determine the most prevalent health concerns impacting women. This is a crucial area of research because the biological makeup of women truly impacts the predisposition to certain health diseases.
The anticipated increase in the demand for therapeutics for women's health can be attributed to a number of factors. This includes the rising incidence of breast cancer among women. Demand for technology has skyrocketed due to the high prevalence of breast cancer in women. The market requires technology for rapid diagnosis, therapy, and recuperation. In addition to breast cancer, the incidence of ovarian and cervical cancer among women is increasing globally. Cancer of the ovary begins in the fallopian tubes, whereas cancer of the cervix begins in the lower uterus. Both conditions are painful and necessitate the use of therapeutic devices for treatment. Radiation therapy, surgery, and chemotherapy are the most common treatments for cervical and ovarian cancer. The most recent radioactive devices and technologies introduced to the market aid in the internal and external treatment of cervical cancer. As more women are diagnosed with severe health conditions, including cancer, in the United Kingdom and around the world, the demand for medical devices, treatments, and services is increasing.
However, some pharmaceutical companies actively invest in developing medication and technologies to prevent and cure female-specific diseases. Some top market players are Novartis AD, Amgen Inc, Abbott Laboratories, and Roche Holdings AG.
The demand for therapeutic devices is growing. As health professionals seek new ways to address health risks, women are increasingly incentivized to invest in these products. Therapeutics includes medical equipment, diagnostic products, radiation devices, and software. North America holds the highest market share in the medical devices market, while Mexico is expected to grow with the highest compound annual growth rate because of continuous product innovation and technological improvements.
Therapeutics for women's health Market Report Coverage
Report Attributes
Details
Market Size in 2021
$XX Mn
Market Size Projection in 2028
$XX Mn
CAGR (2021-2028)
5%
Largest Market
North America
Growth Drivers
Growing awareness about the importance of good health in women and the soaring increase in female-specific diseases
Segmentation
By Type (Infection, Pregnancy, Oncology), By Region (North America, Europe, APAC, LATAM, MEA)
Regional Analysis
North America (US, Canada), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Europe (U.K, Germany, Italy, France, Spain, Russia and Rest of Europe), APAC (China, Japan, India, South Korea, Australia, ASEAN and Rest of Asia Pacific), ME (GCC Countries, Israel, and Rest of Middle East) & Africa (South Africa, North Africa and Central Africa)
Key Companies Covered
Roche, Eli Lilly, Pfizer, AstraZeneca, Novartis, Amgen, and Merck
Key questions answered in this report
COVID 19 impact analysis on global Therapeutics for women’s health industry.
What are the current market trends and dynamics in the Therapeutics for women’s health market and valuable opportunities for emerging players?
What is driving Therapeutics for women’s health market?
What are the key challenges to market growth?
Which segment accounts for the fastest CAGR during the forecast period?
Which product type segment holds a larger market share and why?
Are low and middle-income economies investing in the Therapeutics for women’s health market?
Key growth pockets on the basis of regions, types, applications, and end-users
What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Unique data points of this report
Statistics on Therapeutics for women’s health and spending worldwide
Recent trends across different regions in terms of adoption of Therapeutics for women’s health across industries
Notable developments going on in the industry
Attractive investment proposition for segments as well as geography
Comparative scenario for all the segments for years 2018 (actual) and 2028 (forecast)
Chapter 1 Introduction Study Goals and Objectives What's New in this Update? Reasons for Doing This Study Scope of Report Information Sources Methodology Geographic Breakdown Analyst's Credentials Custom Research Related Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview of Technologies and Global Markets Disease Overview and Definitions Historical Background Market Driving Factors and Opportunities Aging Female Population Government Involvement and Increased Funding Increasing Awareness Regarding Women's Disorders and Treatments Market Restraints Poor Diagnosis Availability of Alternate Treatment Options and Lifestyle Changes Unavailability of Novel Treatments High Treatment Cost of Osteoporosis Opportunities Rising Female Population in Asia-Pacific Increased Demand for Technology Innovation Mergers and Acquisitions
Chapter 4 Impact of COVID-19 Pandemic Implications on Women's Health and Diagnosis Implications on Cancer Treatment Impact on Oncology Pharmaceuticals Market
Chapter 5 Pipeline Assessment and Analysis Women's Health Therapeutics: Key Clinical Trial Developments List of Drugs in Pipeline Overview of Osteoporosis Drug Development Pipeline Late-stage Pipeline Drugs
Chapter 6 Regulatory Structure Overview of Regulations U.S. Canada Europe Japan
Chapter 7 Market Breakdown by Women’s Health Disorder Introduction Menopause-Related Diseases Overview Symptoms Risk Factors Epidemiology and Economic Burden Diagnosis Treatments Market Size and Forecast Postmenopausal Osteoporosis Overview Epidemiology and Economic Burden Diagnosis Treatments Market Size and Forecasts Endometriosis Overview Epidemiology and Economic Burden Diagnosis Treatments Market Size and Forecasts Polycystic Ovary Syndrome Overview Etiology Reducing PCOS Risk Epidemiology and Economic Burden Disease Symptoms and Risk Factors Diagnosis Treatments Market Size and Forecasts Breast Cancer Overview Market Size and Forecasts
Chapter 8 Market Breakdown by Region Introduction North America U.S. Canada Mexico Europe U.K. Germany France Spain Italy Rest of Europe Asia-Pacific China Japan India South Korea Rest of Asia-Pacific Rest of the World South America Middle East and Africa
Chapter 9 Pricing and Reimbursement Overview of Pricing and Reimbursement U.S. Canada Europe Japan
Chapter 10 Competitive Landscape and Key Developments Market Players and Strategies Blockbuster Breast Cancer Pharmaceutical Brands Patent Analysis List of Key Patents Key Developments Mergers and Acquisitions Development of Innovative Products/Novel Product Launch Agreements, Collaborations and Partnerships Key Products
Chapter 11 Company Profiles ABBVIE INC. AMGEN INC. ASAHI KASEI ASTRAZENECA PLC BAYER AG BRISTOL-MYERS SQUIBB DAIICHI SANKYO CO. LTD. ELI LILLY AND CO. EISAI F. HOFFMANN-LA ROCHE LTD. GILEAD SCIENCES INC. JOHNSON & JOHNSON SERVICES INC. MERCK & CO. INC. MERCK KGAA NOVARTIS AG NOVO NORDISK PFIZER INC. SANOFI TAKEDA PHARMACEUTICAL CO. LTD.
Chapter 12 Conclusions: Outlook for Women’s Health Therapeutics Major Developments to Influence Market Therapeutic Developments Demographic and Economic Trends Income Growth in Emerging Markets Future Outlook
Chapter 13 Appendix A: Glossary of Terms
Chapter 14 Appendix B: Industry and Professional Organizations
Chapter 15 Appendix C: Acronyms Used in This Report Acronyms Used in This Report
Follow Douglas Insights For More Industry Updates- @ LinkedIn , Twitter
Similar Market Research Report Comparisons:
Healthcare Track and Trace Solutions Market - Patient safety has become a major concern for healthcare organizations worldwide. According to the World Health Organization (WHO), nearly 1 in 10 medical products circulating in low- and middle-income countries are either substandard or falsified. This highlights the need for effective track and trace solutions that can help ensure that patients receive safe and effective treatments.
Blockchain Technology in Healthcare Market - The application of blockchain technology in healthcare has the potential to create a more secure and efficient system for managing health data. A blockchain is a distributed database that allows for secure, transparent and tamper-proof record-keeping. This makes it an ideal platform for storing and sharing health information, which is often sensitive in nature.
Brain Health Supplements Market - Brain health supplements are organic compounds with positive effects on the brain. One of the main factors fueling the market's expansion is the rising prevalence of neurodegenerative diseases in the world.
About Douglas Insights-
Douglas Insights UK limited is the first company to provide comparison of market research reports by Table of content, price, ratings and number of pages. We understand the value of time. Productivity and efficiency are possible when you take prompt and assured decisions. With our advanced algorithm, filters, and comparison engine, you can compare your preferred reports simultaneously, based on publisher rating, published date, price, and list of tables. Our data portal enables you to find and review the reports from several publishers. You can evaluate numerous reports on the same screen and select the sample for your best match.
CONTACT: Isabella Hawke Douglas Insights +44 7624 248772 isabella@douglasinsights.com
